- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-255
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.35 |
Change
0.000(0.00%) |
Mkt cap ! $352.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 225 | $18.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.50 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 225 | 18.360 |
2 | 383 | 18.130 |
1 | 300 | 18.110 |
1 | 1000 | 18.000 |
1 | 55 | 17.910 |
Price($) | Vol. | No. |
---|---|---|
18.500 | 1000 | 1 |
19.000 | 437 | 1 |
19.700 | 100 | 1 |
19.870 | 202 | 1 |
20.000 | 3400 | 5 |
Last trade - 08.47am 03/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable
The Watchlist
TON
TRITON MINERALS LTD
Adrian Costello, Executive Director
Adrian Costello
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online